Emil Kakkis

Emil Kakkis is an accomplished professional in the pharmaceutical and biotechnology sectors, currently serving as a Board Member at Actio Biosciences, Inc., the EveryLife Foundation for Rare Diseases, and the National Organization for Rare Disorders. Emil Kakkis is the Founder, Chief Executive Officer, and President of Ultragenyx Pharmaceutical Inc. Additionally, Emil Kakkis has held roles as Chief Medical Officer and Development Consultant at BioMarin. Emil Kakkis holds an MD/PhD in biological chemistry from UCLA and a Bachelor of Arts in Biology from Pomona College.